Table 2.
Comparison of baseline characteristics of patients with different alkaline phosphatase, and γ-glutamyltransferase
Factors | ALP > 120 (n = 50) | ALP ≤ 120 (n = 122) | P value | GGT > 115 (n = 48) | GGT ≤ 115 (n = 124) | P value |
Gender | 40 | 99 | 0.835 | 40 | 99 | 0.671 |
Age | 19 | 36 | 0.286 | 18 | 37 | 0.365 |
HBV | 34 | 87 | 0.714 | 35 | 86 | 0.712 |
HCV | 2 | 6 | 1.000 | 3 | 5 | 0.687 |
Cirrhosis | 23 | 36 | 0.051 | 20 | 39 | 0.215 |
AFP | 17 | 49 | 0.493 | 21 | 45 | 0.386 |
Tumor characteristics | ||||||
Size | 39 | 75 | 0.050 | 42 | 72 | < 0.001 |
Number | 10 | 22 | 0.830 | 11 | 21 | 0.387 |
Invasion | 9 | 45 | 0.018 | 16 | 38 | 0.719 |
Lymphnode metastasis | 3 | 3 | 0.358 | 4 | 2 | 0.052 |
ALP: Alkaline phosphatase; GGT: γ-glutamyltransferase; AFP: α-fetoprotein; HBV: Hepatitis B virus; HCV: Hepatitis C virus.